IPP Bureau
Pfizer sets up global drug development centre in Chennai
By IPP Bureau - May 04, 2022
The facility is among 12 centres established worldwide, and the first in Asia
Sona Group partners with Mycelium Biotechnology for R&D in Salem
By IPP Bureau - May 02, 2022
As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceutical solutions through global partners
Xcardia announces first-in-human use of its new Xtractor device
By IPP Bureau - May 02, 2022
The announcement follows FDA 510(k) clearance of device
NORD announces over US $ 100,000 in grant funding available for rare disease research
By IPP Bureau - May 02, 2022
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
CIVCO Radiotherapy to Unveil TotalRT All in One Solution at ESTRO 2022
By IPP Bureau - May 02, 2022
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
World’s first AI software for detecting pancreatic disease on the horizon
By IPP Bureau - May 02, 2022
As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies
Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical
By IPP Bureau - May 02, 2022
Avacc 3 has significant advantages over existing whooping cough vaccines
StanPlus appoints Gurjit Singh as COO and Founding Member
By IPP Bureau - May 02, 2022
He will be leading the business, operations, P&L, and growth strategy for StanPlus
USFDA concludes inspection of Shilpa Medicare with four observations
By IPP Bureau - May 02, 2022
The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory
Physicians foresee an Alzheimer's Disease treatment revolution supported by advanced testing tools
By IPP Bureau - May 02, 2022
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
NHA enlists Pristyn Care as health tech partner for Ayushman Bharat Digital Mission
By IPP Bureau - May 02, 2022
ABDM is a critical integration that leverages an open, interoperable, standards-based digital system that is secure, and maintains confidentiality and privacy of health-related personal information
Dr. Mansukh Mandaviya to chair a three-day health meet at Kevadia in Gujarat
By IPP Bureau - May 02, 2022
State Ministers of Health and Medical Education to Participate in the meeting from 5th to 7th May
Sage Therapeutics and Biogen initiate rolling submission of New Drug Application for Zuranolone
By IPP Bureau - May 02, 2022
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
USFDA approves Rinvoq as an oral treatment for ankylosing spondylitis
By IPP Bureau - May 01, 2022
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Moderna finalizes plan for long-term strategic partnership with Canada
By IPP Bureau - May 01, 2022
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
